Annexon, Inc. (ANNX)
4.535
-0.14
(-2.89%)
USD |
NASDAQ |
Sep 09, 10:30
Annexon Price : 4.535 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 4.76 | 4.785 | 4.64 | 4.67 | 2.140M |
| Sep 04, 2026 | 4.81 | 4.905 | 4.79 | 4.87 | 1.228M |
| Sep 03, 2026 | 4.93 | 5.04 | 4.765 | 4.84 | 2.314M |
| Sep 02, 2026 | 4.90 | 5.075 | 4.78 | 4.93 | 1.842M |
| Sep 01, 2026 | 4.96 | 5.00 | 4.85 | 4.89 | 1.473M |
| Aug 31, 2026 | 4.99 | 5.04 | 4.83 | 4.94 | 2.437M |
| Aug 28, 2026 | 5.18 | 5.205 | 4.945 | 4.97 | 1.619M |
| Aug 27, 2026 | 5.00 | 5.32 | 4.91 | 5.25 | 3.024M |
| Aug 26, 2026 | 5.13 | 5.175 | 4.955 | 4.99 | 2.277M |
| Aug 25, 2026 | 5.13 | 5.225 | 5.085 | 5.15 | 2.942M |
| Aug 24, 2026 | 5.05 | 5.13 | 4.80 | 5.06 | 3.378M |
| Aug 21, 2026 | 5.24 | 5.275 | 5.02 | 5.07 | 1.430M |
| Aug 20, 2026 | 5.41 | 5.465 | 5.105 | 5.18 | 1.670M |
| Aug 19, 2026 | 5.45 | 5.59 | 5.34 | 5.50 | 3.504M |
| Aug 18, 2026 | 5.03 | 5.308 | 5.02 | 5.28 | 2.244M |
| Aug 17, 2026 | 5.26 | 5.29 | 5.06 | 5.13 | 3.625M |
| Aug 14, 2026 | 5.21 | 5.345 | 5.081 | 5.29 | 2.990M |
| Aug 13, 2026 | 5.36 | 5.40 | 5.195 | 5.26 | 3.123M |
| Aug 12, 2026 | 5.06 | 5.415 | 5.00 | 5.33 | 3.950M |
| Aug 11, 2026 | 5.40 | 5.45 | 5.165 | 5.34 | 924796.0 |
| Aug 10, 2026 | 5.39 | 5.505 | 5.265 | 5.39 | 1.960M |
| Aug 07, 2026 | 5.63 | 5.70 | 5.39 | 5.41 | 2.046M |
| Aug 06, 2026 | 5.37 | 5.60 | 5.37 | 5.60 | 3.049M |
| Aug 05, 2026 | 5.40 | 5.43 | 5.26 | 5.37 | 1.771M |
| Aug 04, 2026 | 5.35 | 5.48 | 5.255 | 5.33 | 2.562M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Marker Therapeutics, Inc. | 1.28 |
| Krystal Biotech, Inc. | 346.41 |
| Immix Biopharma, Inc. | 12.86 |
| ACADIA Pharmaceuticals, Inc. | 27.78 |
| Alnylam Pharmaceuticals, Inc. | 254.37 |
Price Related Metrics
| Price to Book Value | 4.256 |
| Earnings Yield | -25.30% |
| Market Cap | 791.83M |